2005 Stock Overview
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
SSY Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$3.78 |
| 52 Week High | HK$5.20 |
| 52 Week Low | HK$3.31 |
| Beta | 0.62 |
| 11 Month Change | -4.55% |
| 3 Month Change | 6.48% |
| 1 Year Change | -22.86% |
| 33 Year Change | -2.58% |
| 5 Year Change | -39.90% |
| Change since IPO | -45.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2005 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | -2.1% | -2.0% | -2.7% |
| 1Y | -22.9% | -9.4% | 10.9% |
Return vs Industry: 2005 underperformed the Hong Kong Pharmaceuticals industry which returned -8.3% over the past year.
Return vs Market: 2005 underperformed the Hong Kong Market which returned 11.3% over the past year.
Price Volatility
| 2005 volatility | |
|---|---|
| 2005 Average Weekly Movement | 5.4% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in HK Market | 19.0% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 2005 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2005's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 5,800 | Jiguang Qu | www.ssygroup.com.hk |
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials.
SSY Group Limited Fundamentals Summary
| 2005 fundamental statistics | |
|---|---|
| Market cap | HK$11.18b |
| Earnings (TTM) | HK$1.37b |
| Revenue (TTM) | HK$6.47b |
8.2x
P/E Ratio1.7x
P/S RatioIs 2005 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2005 income statement (TTM) | |
|---|---|
| Revenue | HK$6.47b |
| Cost of Revenue | HK$2.95b |
| Gross Profit | HK$3.52b |
| Other Expenses | HK$2.15b |
| Earnings | HK$1.37b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.46 |
| Gross Margin | 54.39% |
| Net Profit Margin | 21.11% |
| Debt/Equity Ratio | 47.7% |
How did 2005 perform over the long term?
See historical performance and comparison